During the past decade, Groupe Hospitalier Pitié- Salpétrière; Service Neurologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe Hospitalier Pitié- Salpétrière; Service Neurologie" #1 collaborator was "European Commission" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Pitié- Salpétrière; Service Neurologie" are "Amyotrophic Lateral Sclerosis" (2 trials), "Healthy" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Groupe Hospitalier Pitié- Salpétrière; Service Neurologie" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Pitié- Salpétrière; Service Neurologie" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "50 mL of sodium chloride (0,9%)" (1 trials), "Citalopram 30mg" (1 trials), "Morphine 0,05mg/kg" (1 trials) and "Naloxone 10mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Pitié- Salpétrière; Service Neurologie" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Pitié- Salpétrière; Service Neurologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Groupe Hospitalier Pitié- Salpétrière; Service Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Pitié- Salpétrière; Service Neurologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".